You will be redirected to:

Continue
Logo - Kls
Logo - Kls
  • Playbook
  • Services
    Frame clinical development strategies
    Operationalize clinical development
    Implement RWE and Late Phase projects
    Enable life data science boosters
    Reach the next level in digital innovation
  • Insights
  • Technology
  • Careers
  • About us
    Company purpose
    Life science innovation
    Committed Keyrus
    Regulatory compliance
    Investors
    Management team
    Keyrus Group
    Locations

Speed up the development of clinical study documents

Background

With more than 100,000 employees in 100 countries, our client is a pharmaceutical company based in France and active in many therapeutic areas including oncology and infectious diseases. Their medicines treat 28 million people each year.

Challenge

With the aim to start promptly a retrospective, secondary data use study in oncology, our client entrusted our medical writing team with the development of the clinical study protocol. The study design (including its population and endpoints) was strongly related to the results of an ongoing feasibility study. The challenges were to adapt the study design throughout the process of writing the protocol and to finalize the document within a tight timeframe.

Approach

The development process of the study protocol included two drafts and a final version. Each version was written and reviewed by a lead medical writer according to the sponsor’s recommendations and to the feasibility results, in compliance with best practices and applicable regulations and with the support of one of our biostatisticians. A second medical writer performed a full quality control of each version of the protocol (including data sources, format, style, and consistency).

Key results

01
Delivering a clinical study protocol
02
Speeding up the development of the clinical study protocol
03
Ensuring the quality of clinical documents by working in pairs of medical writers

Benefits

The extensive experience, the flexibility and the proactivity of our medical writing team allowed us to deliver the required document with the highest quality within the agreed timeline, in an efficient and reliable manner.

Share this key play

whatsapptwitter
linkedinfacebookworkplace

More key plays

Piloting through a pivotal study in cataract eye surgery helping patients recover their vision
Medical device approved for Hearing Loss
Accelerate the compliance process of your product portfolio in line with the new Medical Device Regulation (EU 2017/745)
Accelerate the clinical validation of an anti-Covid treatment, thanks to an agile data management
Lower costs & risks associated with indication extensions, thanks to a robust meta-analysis of clinical data
Adapting service platforms (FSP) functionning to fit the client's new outsourcing strategy
Facilitate the provision of an innovative treatment thanks to a Managed Access Program (MAP)
Efficiently conducting a worldwide phase 2 clinical study with multiple partners
Achieving an end-to-end audit approval from Health Canada
Facilitate data mapping to SDTM by leveraging standardisation and A.I.
Logo - Kls
Headquarters

157 Rue Anatole France 92593 Levallois-Perret

Phone:+33 (0)1 41 34 10 00

LinkedInKlsInstagram
PlaybookServicesInsightsTechnologyCareersAbout us
Company purposeLife science innovationCommitted KeyrusRegulatory complianceInvestorsManagement teamKeyrus GroupLocations
Legal notice & Terms of use
Privacy policy
Data protection